Researchers in Taiwan have developed a new targeted therapy drug that preclinical trials suggest could inhibit the growth of tumors in nearly 30 percent of cancer patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
TSMC Arizona chairman to retire; no successor named yet
07/02/2025 11:12 AM - Business
U.S. dollar down in Taipei trading
07/02/2025 10:27 AM - Society
Taiwan headline news
07/02/2025 10:01 AM - Business
Taiwan shares open lower
07/02/2025 09:10 AM - Politics
Taiwan to import Polish blueberries: Foreign minister
07/01/2025 10:24 PM